Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
A wanted man turned himself in after losing a bet he made with police on Facebook - along with promised doughnuts.
Terry Butcher said his son's life had been "tragically cut short" and described him as a "dedicated captain in the British Army".
Through the morning an area of rain will steadily track northeastwards across central England.